Search International and National Patent Collections

1. (WO2018103884) USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE THERAPEUTIC POTENTIAL OF DRUGS

Pub. No.:    WO/2018/103884    International Application No.:    PCT/EP2017/001406
Publication Date: Fri Jun 15 01:59:59 CEST 2018 International Filing Date: Wed Dec 06 00:59:59 CET 2017
IPC: A61K 39/395
C07K 16/30
A61K 39/00
Applicants: OGD2 PHARMA
UNIVERSITE DE NANTES
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
INSTITUT DE CANCEROLOGIE DE L'OUEST
Inventors: BIRKLE, Stéphane
FLEURENCE, Julien
FARAJ, Sébastien
LE DOUSSAL, Jean-Marc
COCHONNEAU, Denis
TERME, Mickaël
ASSOULINE, Brigitte
Title: USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE THERAPEUTIC POTENTIAL OF DRUGS
Abstract:
The present invention relates to a method for delivery of an anti-cancer agent into a cell expressing the OAcGD2 ganglioside by using an antibody recognizing the OAcGD2 ganglioside.